Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients

PLoS ONE - United States
doi 10.1371/journal.pone.0048372
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Can D-Dimer Measurement Reduce the Frequency of Radiological Assessment in Patients Receiving Palliative Imatinib for Gastrointestinal Stromal Tumor (GIST)?

Cancer Investigation
MedicineCancer ResearchOncology
2015English

Neoadjuvant Imatinib for Borderline Resectable GIST

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Mitotic Count and Estimation of the Risk of GIST Recurrence in Patients Treated With Preoperative Imatinib

Clinical Oncology and Research
2019English

Evaluation of Nilotinib in Advanced GIST Previously Treated With Imatinib and Sunitinib

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2011English

The Economic Burden of Gastrointestinal Stromal Tumor (GIST) Recurrence in Patients Who Have Received Adjuvant Imatinib Therapy

Journal of Medical Economics
Health Policy
2014English

GIST Manifesting as a Retroperitoneal Tumor

American Journal of Surgical Pathology
AnatomyForensic MedicinePathologySurgery
2017English

Remarkable Response in a Case of Recurrent Gastrointestinal Stromal Tumor Treated With Low Dose Imatinib

Journal of Nihon University Medical Association
2016English

Fortgeschrittener GIST: Schlechtere Prognose Nach Absetzen Von Imatinib

Im Focus Onkologie
2013English

Long-Term Impact of Molecular Response Fluctuations in Chronic Myeloid Leukaemia Patients Treated With Imatinib

British Journal of Haematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy